Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neurochemistry of Hypomyelination Investigated with MR Spectroscopy.
Role of autophagy in the pathogenesis of multiple sclerosis.
Primary Cutaneous Cryptococcus in a Patient With Multiple Sclerosis Treated With Fingolimod.
Myeloid microvesicles are a marker and therapeutic target for neuroinflammation.
Connexin astrocytopathy and novel therapeutic strategy targeting connexin hemichannels in demyelinating disease.
CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review.
Fingolimod (Gilenya) eligibility extended by NHS England
Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis.
Magnetic Resonance Imaging Predictors of Executive Functioning in Patients with Pediatric-Onset Multiple Sclerosis.
Dealing with excess of zeros in the statistical analysis of magnetic resonance imaging lesion count in multiple sclerosis.
Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice.
Synthesis and biological evaluation of tyrosine modified analogues of the α4β7 integrin inhibitor biotin-R(8)ERY.
Prospective Evaluation of Laparoscopic Assisted Cystectomy and Ileal Conduit in Advanced Multiple Sclerosis.
[Optic Neuritis.]
'Hidden' factors influencing quality of life in patients with multiple sclerosis.
Effect of the time of day on central and peripheral fatigue during 2-min maximal voluntary contractions in persons with multiple sclerosis: gender differences.
The role of IFNβ in the treatment of MSand EAE - In the perspective of inflammasomes.
Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
ADEM Following Malaria.
Alemtuzumab treatment of multiple sclerosis.
Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosis.
Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes.
Multiple Sclerosis: Risk Factors and Their Interactions.
Medical marijuana in neurology.
Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors Remyelinate the Brain and Rescue Behavioral Deficits following Radiation.
Pages
« first
‹ previous
…
304
305
306
307
308
309
310
311
312
…
next ›
last »